iCAD highlights global availability of ProFound Cloud at JFR 2024

iCAD announced its participation in the 72nd edition of the Journees Francophones de Radiologie 2024 Meeting, taking place from October 4-7 in Paris, France. At JFR, iCAD will premier ProFound Cloud, a secure, scalable SaaS platform designed to deliver the company’s advanced AI solutions to healthcare providers worldwide. In its first two full quarters of U.S. availability, ProFound Cloud has processed nearly 100,000 cases, demonstrating rapid early adoption. Achieving processing speeds more than 50% faster than many traditional on-premises solutions, the ProFound Cloud is an efficient solution for deploying the ProFound AI Suite. With recent global distribution partnerships and regulatory clearances, the availability of Profound Cloud is expanding around the globe. The launch of its new Cloud platform represents a key milestone in iCAD’s global expansion. Over the past quarter, iCAD has made significant progress across three key areas-strengthening partnerships, securing new regulatory clearances, and expanding its AI capabilities: Global Distribution Partnerships: iCAD has forged new commercial distribution alliances in countries such as Dominican Republic, France, Spain, Turkey, United Arab Emirates and with leading healthcare technology companies, including Tamer, Ozel and deepc, expanding the availability of its ProFound AI solutions globally. Regulatory Clearances in Key Markets: In line with its global growth strategy, iCAD has recently received regulatory clearances for its ProFound AI platform in South Africa and the United Arab Emirates. ProFound Cloud Expansion: Built on Google Cloud Platform, ProFound Cloud provides a scalable, secure, and affordable platform for healthcare providers to access iCAD’s AI-driven breast health technologies. The platform offers continuous updates and improved operational efficiency, making it a versatile solution for institutions of all sizes.